partial remission rates of diabetes within these groups after gastric bypass versus sleeve gastrectomy were 100% versus 100% for mild diabetes, 97% versus 68% (p=0·0059) for moderate diabetes, and 27% versus 7% (p=0·28) for severe diabetes (appendix p 2). These findings partly support the findings from Aminian and colleagues, 2 showing that gastric bypass was superior to sleeve gastrectomy by inducing remission of diabetes of moderate severity, whereas sleeve gastrectomy was equally effective in patients with mild diabetes but tended to be less effective in those with severe diabetes. However, our results must be interpreted with caution in view of the short followup and fairly small study population. We believe that the IMSS needs to be validated in a sufficiently powered, longer-term randomised controlled trial. Although diabetes remission is an important aim, other possible differences in terms of the beneficial and detrimental effects of different surgical procedures must be considered in the shared decisionmaking process. Additionally, patients
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We thank Bengt Novik for his interest in our randomised controlled Oseberg trial 1 and for the opportunity to respond and present our results stratified according to the Individualized Metabolic Surgery Score (IMSS). 2 The IMSS classifies patients with diabetes according to their chances of partial remission of diabetes (HbA 1c <6·5% off antidiabetes medication). The preoperative characteristics of Oseberg participants, including duration of diabetes and number of antidiabetes medications, did not differ substantially from the characteristics of patients retrospectively included in the study by Aminian and colleagues to construct and validate the IMSS (appendix p 1). 2 The Oseberg study showed partial remission of diabetes after Roux-en-Y gastric bypass in 44 (81%) of 54 and after sleeve gastrectomy in 31 (56%) of 55 patients. 1 22 (20%) of 109 patients had mild diabetes, 62 (57%) had moderate diabetes, and 25 (23%) had severe diabetes (appendix p 1). The
